Skip to main content
. Author manuscript; available in PMC: 2014 Mar 25.
Published in final edited form as: Int J Pharm. 2013 Feb 16;446(0):119–129. doi: 10.1016/j.ijpharm.2013.02.026

Figure 7.

Figure 7

PEGylation by post-insertion of HDAS-PEG attenuates liposome-induced complement activation. The complement proteins in human serum were determined by enzyme-immunoassay after treatment with plain liposomes or HDAS-PEG liposomes for 1 h. C4d and Bb are the markers for classical and alternate pathways, respectively, whereas SC5b is S protein-bound terminal complex. Average titers and standard error of mean were determined for six individual reading (* p < 0.05).